HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47671,
"recordsTotal": 47671,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-title&start=45300",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-title&start=44700",
"results": [
{
"registry_id": "NCT06918119",
"publication_url": "https://clinicaltrials.gov/study/NCT06918119",
"title": "Characterization of Transcutaneous Spinal Cord Stimulation for Enabling Reflex Motor Evoked Responses in Children and Youth With Spina Bifida",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961344",
"publication_url": "https://clinicaltrials.gov/study/NCT06961344",
"title": "An Open-label Extension Study Evaluating the Safety of Zagociguat in Participants With MELAS Who Completed TIS6463-203",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tisento Therapeutics",
"sponsor_slug": "tisento-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07196501",
"publication_url": "https://clinicaltrials.gov/study/NCT07196501",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Maintenance of Effect of NBI-1065845 as an Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurocrine Biosciences",
"sponsor_slug": "neurocrine-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160725",
"publication_url": "https://clinicaltrials.gov/study/NCT07160725",
"title": "A Phase 1/2a, First-in-human, Open-label Study of BMS-986517 as Monotherapy in Adult Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06701656",
"publication_url": "https://clinicaltrials.gov/study/NCT06701656",
"title": "Phase 2 Clinical Platform Trial Investigating Multiple Therapeutic Options for the Treatment of Hospitalized Patients With Acute Respiratory Distress Syndrome (ARDS)",
"has_exemption": false,
"start_date": "2025-10-28",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PPD DEVELOPMENT, LP",
"sponsor_slug": "ppd-development-lp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112053",
"publication_url": "https://clinicaltrials.gov/study/NCT07112053",
"title": "A Phase II Study of STEMVAC Vaccine Therapy for Patients With Hormone Receptor Positive Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187115",
"publication_url": "https://clinicaltrials.gov/study/NCT07187115",
"title": "A Global Randomized Trial Comparing Pulsed Field Ablation of Pulmonary Veins Plus Extra-PV Sources Utilizing Electrographic Flow Mapping Versus Pulmonary Veins Plus Posterior Wall in Persistent Atrial Fibrillation Patients.",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06902714",
"publication_url": "https://clinicaltrials.gov/study/NCT06902714",
"title": "Evaluating the Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty: A Randomized Control Trial",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07304024",
"publication_url": "https://clinicaltrials.gov/study/NCT07304024",
"title": "A Double-Blinded, Placebo-Controlled, Randomized, Phase 1/2a Clinical Study to Test the Safety and Efficacy of a Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07155200",
"publication_url": "https://clinicaltrials.gov/study/NCT07155200",
"title": "Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06956404",
"publication_url": "https://clinicaltrials.gov/study/NCT06956404",
"title": "Transcranial Photobiomodulation in Older Adults With Traumatic Brain Injury: Effects on Cerebral Blood Flow and Cognition",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07033598",
"publication_url": "https://clinicaltrials.gov/study/NCT07033598",
"title": "A Randomized Phase 2 Study of Pacritinib vs. Hydroxyurea in Patients With Advanced Proliferative Chronic Myelomonocytic Leukemia",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Theradex",
"sponsor_slug": "theradex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06444412",
"publication_url": "https://clinicaltrials.gov/study/NCT06444412",
"title": "GA-68 PSMA-11 PET To Evaluate Malignant Glioma Recurrence - A Pilot Study",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06904378",
"publication_url": "https://clinicaltrials.gov/study/NCT06904378",
"title": "Phase I/II Clinical Trial of Ontegimod and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma: Reprogramming Tumor-associated Myeloid Cells",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06790602",
"publication_url": "https://clinicaltrials.gov/study/NCT06790602",
"title": "A Single-arm, Open-label, Phase II Trial of Cemiplimab Plus Gemcitabine as Second-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Harboring SWItch/Sucrose Non-Fermentable (SWI/SNF) Alterations.",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06746753",
"publication_url": "https://clinicaltrials.gov/study/NCT06746753",
"title": "Dysfunctional Renin-Angiotensin System in Septic Shock",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166133",
"publication_url": "https://clinicaltrials.gov/study/NCT07166133",
"title": "GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222332",
"publication_url": "https://clinicaltrials.gov/study/NCT07222332",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Baricitinib to Preserve Beta Cell Function in Participants Newly Diagnosed With Type 1 Diabetes Aged ≥1 to <36 Years",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339176",
"publication_url": "https://clinicaltrials.gov/study/NCT07339176",
"title": "A Phase 1/2 Open-Label, Dose Finding and Expansion Study to Investigate the Safety and Effectiveness and Determination of the Optimal Dose of N17350 Administered Intratumorally in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Onchilles Pharma Inc",
"sponsor_slug": "onchilles-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224100",
"publication_url": "https://clinicaltrials.gov/study/NCT07224100",
"title": "Phase II Study of Dose-Adjusted EPOCH ± Rituximab + Ponatinib for Adults With Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06906029",
"publication_url": "https://clinicaltrials.gov/study/NCT06906029",
"title": "Abdominal aBscess Catheter Sclerotherapy (ABCS)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07131722",
"publication_url": "https://clinicaltrials.gov/study/NCT07131722",
"title": "An Open-Label, Dose-Finding, Phase 1/2a Study to Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PRG Science & Technology Co., Ltd.",
"sponsor_slug": "prg-science-technology-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06987383",
"publication_url": "https://clinicaltrials.gov/study/NCT06987383",
"title": "Vibegron - A Novel Treatment for Multisystem Functional Decline in Aging and Obesity",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214194",
"publication_url": "https://clinicaltrials.gov/study/NCT07214194",
"title": "Vagus Nerve Stimulation to Enhance Memory in Aging",
"has_exemption": false,
"start_date": "2027-02-28",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06005662",
"publication_url": "https://clinicaltrials.gov/study/NCT06005662",
"title": "Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial",
"has_exemption": false,
"start_date": "2027-04-30",
"completion_date": "2028-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03675893",
"publication_url": "https://clinicaltrials.gov/study/NCT03675893",
"title": "RESOLVE: letRozole abEmaciclib combinationS in endOmetriaL and oVarian cancEr: A Multi-Cohort Phase 2 Study of Letrozole/Abemaciclib Alone and in Combination With Metformin, Zotatifin and Gedatolisib",
"has_exemption": false,
"start_date": "2018-12-24",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03746769",
"publication_url": "https://clinicaltrials.gov/study/NCT03746769",
"title": "Improving Islet Transplantation Outcomes With Gastrin",
"has_exemption": false,
"start_date": "2019-07-07",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04164173",
"publication_url": "https://clinicaltrials.gov/study/NCT04164173",
"title": "Hyperinflation Respiratory Therapies in Cardiac Surgery Patients: A Randomized, Observer-Blinded, Prospective Clinical Trial",
"has_exemption": false,
"start_date": "2020-06-15",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05541016",
"publication_url": "https://clinicaltrials.gov/study/NCT05541016",
"title": "DART 2.0: ctHPV-DNA Informed De-Escalated Adjuvant and Definitive Radiation Therapy",
"has_exemption": false,
"start_date": "2023-02-21",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05800587",
"publication_url": "https://clinicaltrials.gov/study/NCT05800587",
"title": "Phase II Study of Dose Attenuated Chemotherapy in Patients With Lung Cancer and Age > 70 and/or Comorbidities",
"has_exemption": false,
"start_date": "2023-02-22",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fox Chase Cancer Center",
"sponsor_slug": "fox-chase-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05588141",
"publication_url": "https://clinicaltrials.gov/study/NCT05588141",
"title": "A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05770531",
"publication_url": "https://clinicaltrials.gov/study/NCT05770531",
"title": "A Randomized Clinical Trial Comparing ctDNA-Directed Therapy Change With Standard of Care in Patients With Metastatic Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2023-08-04",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06143059",
"publication_url": "https://clinicaltrials.gov/study/NCT06143059",
"title": "Sex and Sex Hormone Factors Influencing Acute Alcohol Effects on Sleep Physiology",
"has_exemption": false,
"start_date": "2024-01-08",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Lauren Whitehurst",
"sponsor_slug": "lauren-whitehurst",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04915183",
"publication_url": "https://clinicaltrials.gov/study/NCT04915183",
"title": "Phase II Interventional Study Using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute on Deafness and Other Communication Disorders (NIDCD)",
"sponsor_slug": "national-institute-on-deafness-and-other-communication-disorders-nidcd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06529406",
"publication_url": "https://clinicaltrials.gov/study/NCT06529406",
"title": "Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod (COAST: CD20 and Ozanimod Sequencing Trial)",
"has_exemption": false,
"start_date": "2024-07-29",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06989099",
"publication_url": "https://clinicaltrials.gov/study/NCT06989099",
"title": "Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial",
"has_exemption": false,
"start_date": "2024-09-24",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06517641",
"publication_url": "https://clinicaltrials.gov/study/NCT06517641",
"title": "A Phase II Trial of Non-Myeloablative Conditioning and Transplantation of Haploidentical Related, Partially HLA-Mismatched, or Matched Unrelated Bone Marrow for Newly Diagnosed Patients With Severe Aplastic Anemia",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839053",
"publication_url": "https://clinicaltrials.gov/study/NCT06839053",
"title": "Escalated Inpatient Ramp-Up of Sonrotoclax in Patients With Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and Mantle Cell Lymphoma (MCL) (SONIC Study)",
"has_exemption": false,
"start_date": "2025-06-02",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076095",
"publication_url": "https://clinicaltrials.gov/study/NCT07076095",
"title": "A Phase II/III Study to Compare IBB0979 in Combination With Topotecan Versus Topotecan in Subjects With Relapsed Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SUNHO（China）BioPharmaceutical CO., Ltd.",
"sponsor_slug": "sunhochinabiopharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07062003",
"publication_url": "https://clinicaltrials.gov/study/NCT07062003",
"title": "A Dose Finding Study of MiniBeam RadioTherapy for Skin and Superficial Soft Tissue Tumors (MBRT1)",
"has_exemption": false,
"start_date": "2025-08-11",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06127550",
"publication_url": "https://clinicaltrials.gov/study/NCT06127550",
"title": "Effect of Non-invasive Vagus Nerve Stimulation on Letter Learning in Dyslexia",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2028-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136624",
"publication_url": "https://clinicaltrials.gov/study/NCT06136624",
"title": "A Phase 3 Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) Previously Treated With Next-generation Hormonal Agent (NHA) and Taxane-based Chemotherapy (OMAHA-003)",
"has_exemption": false,
"start_date": "2023-12-31",
"completion_date": "2028-08-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06997588",
"publication_url": "https://clinicaltrials.gov/study/NCT06997588",
"title": "Study Assessing the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)",
"has_exemption": false,
"start_date": "2025-10-09",
"completion_date": "2028-08-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07087860",
"publication_url": "https://clinicaltrials.gov/study/NCT07087860",
"title": "MC220503 Randomized Phase II Rescuing Cancer Immunotherapy With Plasma Exchange in Bladder Cancer 1 (ReCIPE-B1)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-08-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07124520",
"publication_url": "https://clinicaltrials.gov/study/NCT07124520",
"title": "Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative Functional Outcomes and Patient-Reported Outcomes After Partial Glossectomy or Hemiglossectomy for Oral Tongue Cancer, A Pilot Study",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-08-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07351058",
"publication_url": "https://clinicaltrials.gov/study/NCT07351058",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once-Weekly RO7795068 Administered to Participants With Obesity or Overweight and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2028-08-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07351045",
"publication_url": "https://clinicaltrials.gov/study/NCT07351045",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Once-Weekly RO7795068 Administered to Participants With Obesity or Overweight Without Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2028-08-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011810",
"publication_url": "https://clinicaltrials.gov/study/NCT07011810",
"title": "Axatilimab for Sclerotic Chronic Graft-Versus-Host Disease",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-08-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221019",
"publication_url": "https://clinicaltrials.gov/study/NCT07221019",
"title": "Single-Shot Exparel Versus Catheters for Lower Extremity Orthopedic Trauma Patients",
"has_exemption": false,
"start_date": "2025-09-12",
"completion_date": "2028-08-11",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05540327",
"publication_url": "https://clinicaltrials.gov/study/NCT05540327",
"title": "A Phase II, Double-blind, Dose-Ranging, Parallel, Long-term Extension Study to Evaluate the Safety and Efficacy of Enpatoran in Participants With Subacute Cutaneous Lupus Erythematosus, Discoid Lupus Erythematosus and/or Systemic Lupus Erythematosus Having Completed the WILLOW (MS200569_0003) Study Treatment (WILLOW LTE)",
"has_exemption": false,
"start_date": "2022-09-16",
"completion_date": "2028-08-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",
"sponsor_slug": "merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-germany",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05989763",
"publication_url": "https://clinicaltrials.gov/study/NCT05989763",
"title": "Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis",
"has_exemption": false,
"start_date": "2024-02-17",
"completion_date": "2028-08-14",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06356129",
"publication_url": "https://clinicaltrials.gov/study/NCT06356129",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Chemotherapy vs Placebo Plus R-CHOP Chemotherapy in Participants With Previously Untreated High-risk Large B-cell Lymphoma (GOLSEEK-1)",
"has_exemption": false,
"start_date": "2024-06-19",
"completion_date": "2028-08-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581003",
"publication_url": "https://clinicaltrials.gov/study/NCT06581003",
"title": "Hyperbaric Oxygen Treatment for Veterans With Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of South Florida",
"sponsor_slug": "university-of-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07030257",
"publication_url": "https://clinicaltrials.gov/study/NCT07030257",
"title": "A Multi-Center, Open Label, Phase 1/2 Study of CP-383, in Patients With Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-27",
"completion_date": "2028-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Tasca Therapeutics",
"sponsor_slug": "tasca-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06007937",
"publication_url": "https://clinicaltrials.gov/study/NCT06007937",
"title": "A Phase 1/2 Study of Combination Lorlatinib and Ramucirumab in Patients With Advanced ALK-rearranged Lung Cancers",
"has_exemption": false,
"start_date": "2023-08-17",
"completion_date": "2028-08-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843967",
"publication_url": "https://clinicaltrials.gov/study/NCT06843967",
"title": "A Phase Ib/II Study of the Mirdametinib in Combination With Palbociclib in Patients With Advanced Dedifferentiated Liposarcoma",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2028-08-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06292780",
"publication_url": "https://clinicaltrials.gov/study/NCT06292780",
"title": "A Phase 1/2 Study of Linvoseltamab in Patients With Relapsed or Refractory Systemic Light Chain Amyloidosis",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2028-08-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05985915",
"publication_url": "https://clinicaltrials.gov/study/NCT05985915",
"title": "A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.",
"has_exemption": false,
"start_date": "2023-10-27",
"completion_date": "2028-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06425549",
"publication_url": "https://clinicaltrials.gov/study/NCT06425549",
"title": "A Multicenter, Randomized, Parallel-Group, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112378",
"publication_url": "https://clinicaltrials.gov/study/NCT07112378",
"title": "A Randomized Study Evaluating 2 Dose Regimens of Dupilumab in Children ≥6 Months of Age Weighing ≥5 to <15 kg With Active Eosinophilic Esophagitis",
"has_exemption": false,
"start_date": "2026-01-13",
"completion_date": "2028-08-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06331312",
"publication_url": "https://clinicaltrials.gov/study/NCT06331312",
"title": "A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR)",
"has_exemption": false,
"start_date": "2024-06-28",
"completion_date": "2028-08-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06597565",
"publication_url": "https://clinicaltrials.gov/study/NCT06597565",
"title": "A Phase II Study of ACR-368 and Low Dose Gemcitabine Combination Therapy in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-09-25",
"completion_date": "2028-08-23",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07173153",
"publication_url": "https://clinicaltrials.gov/study/NCT07173153",
"title": "Phase I/II Intrathecal Gene Delivery Clinical Trial of scAAV9.P546.SLC6A1 for SLC6A1 Neurodevelopmental Disorder",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2028-08-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Emily de los Reyes",
"sponsor_slug": "emily-de-los-reyes",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06165341",
"publication_url": "https://clinicaltrials.gov/study/NCT06165341",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease With METAVIR Stage F1 Fibrosis",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2028-08-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06780449",
"publication_url": "https://clinicaltrials.gov/study/NCT06780449",
"title": "Long-term Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema 2.4 mg/2.4 mg) Once Weekly Versus Placebo in Participants With Obesity",
"has_exemption": false,
"start_date": "2025-02-10",
"completion_date": "2028-08-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06531824",
"publication_url": "https://clinicaltrials.gov/study/NCT06531824",
"title": "A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2028-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858397",
"publication_url": "https://clinicaltrials.gov/study/NCT06858397",
"title": "An Open Label, Dose Range, Proof-of-Concept Study to Assess the Safety and Efficacy of HM15421/GC1134A in Patients With Fabry Disease",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GC Biopharma Corp",
"sponsor_slug": "gc-biopharma-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06975150",
"publication_url": "https://clinicaltrials.gov/study/NCT06975150",
"title": "A Randomized, Double-blind, Placebo-controlled, Parallel Group, 12 Weeks, Phase 2b Clinical Study to Evaluate the Efficacy and Safety of HK-660S in Patients With Primary Sclerosing Cholangitis (PSC)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CuromeBiosciences",
"sponsor_slug": "curomebiosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224152",
"publication_url": "https://clinicaltrials.gov/study/NCT07224152",
"title": "NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-08-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02530073",
"publication_url": "https://clinicaltrials.gov/study/NCT02530073",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2015-09-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Connecticut Children's Medical Center",
"sponsor_slug": "connecticut-childrens-medical-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03008408",
"publication_url": "https://clinicaltrials.gov/study/NCT03008408",
"title": "A Phase II, Randomized Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (LEE011) in Patients With Advanced or Recurrent Endometrial Carcinoma",
"has_exemption": false,
"start_date": "2017-08-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03516279",
"publication_url": "https://clinicaltrials.gov/study/NCT03516279",
"title": "Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease",
"has_exemption": false,
"start_date": "2019-06-26",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03929432",
"publication_url": "https://clinicaltrials.gov/study/NCT03929432",
"title": "Treatment Outcomes and Brain Mechanisms Associated With Non-Invasive Neuromodulation in Post-Stroke Aphasia",
"has_exemption": false,
"start_date": "2019-09-03",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03875378",
"publication_url": "https://clinicaltrials.gov/study/NCT03875378",
"title": "Transdermal Estrogen for the Treatment of Bone Loss in Women With Anorexia Nervosa",
"has_exemption": false,
"start_date": "2020-08-28",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pouneh K. Fazeli, MD",
"sponsor_slug": "pouneh-k-fazeli-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04873362",
"publication_url": "https://clinicaltrials.gov/study/NCT04873362",
"title": "A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy",
"has_exemption": false,
"start_date": "2021-05-04",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05004116",
"publication_url": "https://clinicaltrials.gov/study/NCT05004116",
"title": "Phase 1/2 Study of TPX-0005 (Repotrectinib) in Combination With Chemotherapy in Pediatric and Young Adult Subjects With Advanced or Metastatic Solid Tumors and Primary Central Nervous System Tumors",
"has_exemption": false,
"start_date": "2021-08-09",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747431",
"publication_url": "https://clinicaltrials.gov/study/NCT04747431",
"title": "A Phase 1b Open-Label, Multicenter, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacodynamic Effects of a Single Dose of PBFT02 Delivered Into the ICM of Adults With FTD and Mutations in the GRN or C9ORF72 Genes",
"has_exemption": false,
"start_date": "2021-09-14",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Passage Bio, Inc.",
"sponsor_slug": "passage-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04831580",
"publication_url": "https://clinicaltrials.gov/study/NCT04831580",
"title": "A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer (ROCC)",
"has_exemption": false,
"start_date": "2022-03-22",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GOG Foundation",
"sponsor_slug": "gog-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05426733",
"publication_url": "https://clinicaltrials.gov/study/NCT05426733",
"title": "An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children With Biliary Atresia (BOLD-EXT)",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Albireo, an Ipsen Company",
"sponsor_slug": "albireo-an-ipsen-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05467891",
"publication_url": "https://clinicaltrials.gov/study/NCT05467891",
"title": "A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer",
"has_exemption": false,
"start_date": "2022-09-13",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oana Danciu",
"sponsor_slug": "oana-danciu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05456503",
"publication_url": "https://clinicaltrials.gov/study/NCT05456503",
"title": "Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Disease Using the PET Ligand [18F]-PI-2620",
"has_exemption": false,
"start_date": "2022-09-19",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05501756",
"publication_url": "https://clinicaltrials.gov/study/NCT05501756",
"title": "Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Diseases",
"has_exemption": false,
"start_date": "2023-01-11",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05585554",
"publication_url": "https://clinicaltrials.gov/study/NCT05585554",
"title": "Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy (LAP-ABLATE)",
"has_exemption": false,
"start_date": "2023-07-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Viewray Inc.",
"sponsor_slug": "viewray-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06000787",
"publication_url": "https://clinicaltrials.gov/study/NCT06000787",
"title": "Molecular Characterization Trial for the Harvard/UCSF ROBIN Center: Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science",
"has_exemption": false,
"start_date": "2023-09-19",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05782907",
"publication_url": "https://clinicaltrials.gov/study/NCT05782907",
"title": "A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib With Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06181136",
"publication_url": "https://clinicaltrials.gov/study/NCT06181136",
"title": "A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Denali Therapeutics Inc.",
"sponsor_slug": "denali-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05953610",
"publication_url": "https://clinicaltrials.gov/study/NCT05953610",
"title": "Endotypic Traits and Obstructive Sleep Apnea Surgery",
"has_exemption": false,
"start_date": "2024-01-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05237505",
"publication_url": "https://clinicaltrials.gov/study/NCT05237505",
"title": "The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)",
"has_exemption": false,
"start_date": "2024-02-13",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05753046",
"publication_url": "https://clinicaltrials.gov/study/NCT05753046",
"title": "Perioperative Laparoscopic Transversus Abdominis Plane Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corewell Health East",
"sponsor_slug": "corewell-health-east",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06242782",
"publication_url": "https://clinicaltrials.gov/study/NCT06242782",
"title": "Vertical Ridge Augmentation Strategies: An Adaptive Randomised Controlled Clinical Trial",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University College, London",
"sponsor_slug": "university-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06316297",
"publication_url": "https://clinicaltrials.gov/study/NCT06316297",
"title": "A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age",
"has_exemption": false,
"start_date": "2024-04-05",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06290063",
"publication_url": "https://clinicaltrials.gov/study/NCT06290063",
"title": "Rocky Mountain Cannabis Research Center - Cannabidiol and Older Adult Cannabis Users: A Randomized, Placebo-Controlled Study",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06082167",
"publication_url": "https://clinicaltrials.gov/study/NCT06082167",
"title": "A Phase 2/3, Randomized, Double-Blind, Controlled Study of Zanzalintinib (XL092) in Combination With Pembrolizumab vs Pembrolizumab in First-Line Treatment of Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-06-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Exelixis",
"sponsor_slug": "exelixis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06285643",
"publication_url": "https://clinicaltrials.gov/study/NCT06285643",
"title": "A Phase 2, Randomized, Double-blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults With Moderate Stage Parkinson's Disease",
"has_exemption": false,
"start_date": "2024-06-11",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AskBio Inc",
"sponsor_slug": "askbio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06239194",
"publication_url": "https://clinicaltrials.gov/study/NCT06239194",
"title": "A Phase 1/2a, Multicenter, First-in-human, Open-label Clinical Trial Evaluating MDX2001 Monotherapy in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-06-12",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ModeX Therapeutics, An OPKO Health Company",
"sponsor_slug": "modex-therapeutics-an-opko-health-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05826912",
"publication_url": "https://clinicaltrials.gov/study/NCT05826912",
"title": "Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449222",
"publication_url": "https://clinicaltrials.gov/study/NCT06449222",
"title": "A Phase II, Multi-site, Randomized, Open-label Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of BNT327 at Two Dose Levels in Combination With Chemotherapeutic Agents as First- and Second-line Treatment in Triple-negative Breast Cancer",
"has_exemption": false,
"start_date": "2024-08-26",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06377852",
"publication_url": "https://clinicaltrials.gov/study/NCT06377852",
"title": "Comparing Oral Drug Dosing Strategies in Older Patients With Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "American Society of Clinical Oncology",
"sponsor_slug": "american-society-of-clinical-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06399653",
"publication_url": "https://clinicaltrials.gov/study/NCT06399653",
"title": "Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136546",
"publication_url": "https://clinicaltrials.gov/study/NCT06136546",
"title": "The Role of Inflammation in Cognitive Dysfunction in Acute Depression as Determined by Experimental Inhibition of Tumor Necrosis Factor-alpha Signaling in a Randomized Controlled Trial.",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06785116",
"publication_url": "https://clinicaltrials.gov/study/NCT06785116",
"title": "A Randomized, Placebo-controlled Trial of DAPAgliflozin for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies",
"has_exemption": false,
"start_date": "2025-03-02",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06742996",
"publication_url": "https://clinicaltrials.gov/study/NCT06742996",
"title": "A Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06672822",
"publication_url": "https://clinicaltrials.gov/study/NCT06672822",
"title": "An Open Label Evaluation of Intralesional Injection of Sodium Thiosulfate in the Treatment of Cutaneous or Tendon Calcinosis in Connective Tissue Disease",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Robyn T. Domsic, MD, MPH",
"sponsor_slug": "robyn-t-domsic-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07032662",
"publication_url": "https://clinicaltrials.gov/study/NCT07032662",
"title": "A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06265584",
"publication_url": "https://clinicaltrials.gov/study/NCT06265584",
"title": "Phase II Clinical Trial of 2 Step ATG Combined With Tacrolimus and Mini Methotrexate for Prevention of Acute GVHD Post Reduced Intensity Allogeneic Stem Cell Transplant",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943521",
"publication_url": "https://clinicaltrials.gov/study/NCT06943521",
"title": "A Phase I/II, Dose-escalation and Dose-optimization Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of MT-4561 in Patients With Various Advanced Solid Tumors and to Evaluate Effect of MT-4561 on Pharmacokinetics of Oral Midazolam",
"has_exemption": false,
"start_date": "2025-04-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tanabe Pharma America, Inc.",
"sponsor_slug": "tanabe-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06939283",
"publication_url": "https://clinicaltrials.gov/study/NCT06939283",
"title": "A Phase 1b/2 Multisite Dose- and Regimen-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma (NHL)",
"has_exemption": false,
"start_date": "2025-05-07",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Werewolf Therapeutics, Inc.",
"sponsor_slug": "werewolf-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07001800",
"publication_url": "https://clinicaltrials.gov/study/NCT07001800",
"title": "A Phase 2b/3, Randomized, Double-Blinded, Placebo Controlled Study ChecKing the Efficacy and Safety of ATAciguat to Slow the Progression of VaLvular DYsfunction in Participants With Moderate Calcific Aortic Valve STenosis",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kardigan, Inc.",
"sponsor_slug": "kardigan-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678841",
"publication_url": "https://clinicaltrials.gov/study/NCT06678841",
"title": "Randomized Trial of ELEVATEd Cardiac Pacing Rate for Personalized Treatment of Heart Failure With Preserved Ejection Fraction (ELEVATE-HFpEF)",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Cardiac Rhythm and Heart Failure",
"sponsor_slug": "medtronic-cardiac-rhythm-and-heart-failure",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06933329",
"publication_url": "https://clinicaltrials.gov/study/NCT06933329",
"title": "Phase 2 Study of Zelenectide Pevedotin in Participants With Previously-Treated NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BicycleTx Limited",
"sponsor_slug": "bicycletx-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07030699",
"publication_url": "https://clinicaltrials.gov/study/NCT07030699",
"title": "Epcoritamab With Lenalidomide and Tafasitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B Cell Lymphoma (DLBCL)",
"has_exemption": false,
"start_date": "2025-08-13",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06998407",
"publication_url": "https://clinicaltrials.gov/study/NCT06998407",
"title": "A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-023 as a Single Agent, and in Combination With AVZO-021 and/or Endocrine Therapy in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06965127",
"publication_url": "https://clinicaltrials.gov/study/NCT06965127",
"title": "Enhancing Walking and Independence After Incomplete SCI With a Fully Implanted Neuroprosthesis",
"has_exemption": false,
"start_date": "2025-08-27",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Louis Stokes VA Medical Center",
"sponsor_slug": "louis-stokes-va-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06749145",
"publication_url": "https://clinicaltrials.gov/study/NCT06749145",
"title": "Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06741579",
"publication_url": "https://clinicaltrials.gov/study/NCT06741579",
"title": "Mechanisms of Stimulation for Pain Alleviation",
"has_exemption": false,
"start_date": "2025-09-26",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06813820",
"publication_url": "https://clinicaltrials.gov/study/NCT06813820",
"title": "RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial",
"has_exemption": false,
"start_date": "2025-09-29",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioVentrix",
"sponsor_slug": "bioventrix",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07125222",
"publication_url": "https://clinicaltrials.gov/study/NCT07125222",
"title": "Use of Gocovri to Improve Disability Due to Radiation Encephalopathy",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06062888",
"publication_url": "https://clinicaltrials.gov/study/NCT06062888",
"title": "Multi-institutional Phase 2/3 Trial of Fresh Frozen Plasma (FFP) in Patients With Moderate to Severe Traumatic Brain Injury (TBI)",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957418",
"publication_url": "https://clinicaltrials.gov/study/NCT06957418",
"title": "The Alzheimer's Disease Tau Platform Clinical Trial",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul S. Aisen",
"sponsor_slug": "paul-s-aisen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06723015",
"publication_url": "https://clinicaltrials.gov/study/NCT06723015",
"title": "Study of Tau PET Outcomes in Patients Receiving Anti-amyloid Immunotherapies",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07100782",
"publication_url": "https://clinicaltrials.gov/study/NCT07100782",
"title": "Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07167966",
"publication_url": "https://clinicaltrials.gov/study/NCT07167966",
"title": "Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul S. Aisen",
"sponsor_slug": "paul-s-aisen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160205",
"publication_url": "https://clinicaltrials.gov/study/NCT07160205",
"title": "A Phase 2-Phase 3, Double-blinded, Randomized, Dose-repeating, Cross-over Study to Assess the Safety and Efficacy of Allogeneic ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM)",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Restem, LLC.",
"sponsor_slug": "restem-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07102940",
"publication_url": "https://clinicaltrials.gov/study/NCT07102940",
"title": "Eftilagimod Alpha in Combination With Neoadjuvant Chemotherapy in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer",
"has_exemption": false,
"start_date": "2026-01-02",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957691",
"publication_url": "https://clinicaltrials.gov/study/NCT06957691",
"title": "Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)",
"has_exemption": false,
"start_date": "2026-01-14",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shehzad Basaria, M.D.",
"sponsor_slug": "shehzad-basaria-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06943859",
"publication_url": "https://clinicaltrials.gov/study/NCT06943859",
"title": "Ketamine for the Treatment of Opioid Use Disorder",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07362017",
"publication_url": "https://clinicaltrials.gov/study/NCT07362017",
"title": "A Multicenter, Open Label Study to Investigate the Safety and Efficacy of Ponesimod in the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanda Pharmaceuticals",
"sponsor_slug": "vanda-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07348627",
"publication_url": "https://clinicaltrials.gov/study/NCT07348627",
"title": "Opioid-Sparing Joint Replacement - Single Site Randomized Control Trial",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04056013",
"publication_url": "https://clinicaltrials.gov/study/NCT04056013",
"title": "Vicryl Rapide Versus Nonabsorbable Suture in Repair of Simple Traumatic Extremity and Trunk Lacerations in Adult Patients",
"has_exemption": false,
"start_date": "2019-09-26",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04140487",
"publication_url": "https://clinicaltrials.gov/study/NCT04140487",
"title": "A Phase I/II Study of Azacitidine, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation",
"has_exemption": false,
"start_date": "2019-12-17",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04209686",
"publication_url": "https://clinicaltrials.gov/study/NCT04209686",
"title": "Phase 2 Study of Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma",
"has_exemption": false,
"start_date": "2020-07-31",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05100095",
"publication_url": "https://clinicaltrials.gov/study/NCT05100095",
"title": "Hypofractionated Radiation Therapy for Merkel Cell Carcinoma",
"has_exemption": false,
"start_date": "2021-12-14",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929729",
"publication_url": "https://clinicaltrials.gov/study/NCT05929729",
"title": "Neurovascular and Neurocognitive Consequences of Iron Deficiency Anemia",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06027086",
"publication_url": "https://clinicaltrials.gov/study/NCT06027086",
"title": "A Phase 1b/2 Study of Glutamine Antagonist DRP-104 in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Hepatocellular Carcinoma (FLC)",
"has_exemption": false,
"start_date": "2024-02-12",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04875702",
"publication_url": "https://clinicaltrials.gov/study/NCT04875702",
"title": "Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-22",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919329",
"publication_url": "https://clinicaltrials.gov/study/NCT05919329",
"title": "Modulation of PSMA Expression in Castration Sensitive and Castration Resistant Prostate Cancer in Response to Hormonal Therapy",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06253117",
"publication_url": "https://clinicaltrials.gov/study/NCT06253117",
"title": "Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.",
"has_exemption": false,
"start_date": "2024-06-27",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06573996",
"publication_url": "https://clinicaltrials.gov/study/NCT06573996",
"title": "The Effect of Intraoral Transcutaneous Electrical Nerve Stimulation (TENS) on Pain Perception During Orthodontic Alignment and Leveling: a Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of the Pacific",
"sponsor_slug": "university-of-the-pacific",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06415591",
"publication_url": "https://clinicaltrials.gov/study/NCT06415591",
"title": "Auricular Neuromodulation in Veterans With Fibromyalgia: A Randomized, Sham-Controlled Study",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06567314",
"publication_url": "https://clinicaltrials.gov/study/NCT06567314",
"title": "Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2024-12-02",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06883162",
"publication_url": "https://clinicaltrials.gov/study/NCT06883162",
"title": "Randomized Controlled Trial of Varenicline to Treat Tobacco and Cannabis Co-Use (RECLAIM)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651593",
"publication_url": "https://clinicaltrials.gov/study/NCT06651593",
"title": "Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07105709",
"publication_url": "https://clinicaltrials.gov/study/NCT07105709",
"title": "A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of GSK4527226 (AL101) in Participants With Early Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07103616",
"publication_url": "https://clinicaltrials.gov/study/NCT07103616",
"title": "Individual Cerebral Hemodynamic Oxygenation Relationships - ICHOR 4",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07016399",
"publication_url": "https://clinicaltrials.gov/study/NCT07016399",
"title": "A Phase II Neoadjuvant Clinical Trial of the Androgen Receptor Inhibitor Darolutamide in Early-Stage Androgen Receptor Positive (AR+) Triple-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vandana Abramson",
"sponsor_slug": "vandana-abramson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07113743",
"publication_url": "https://clinicaltrials.gov/study/NCT07113743",
"title": "Part B- Phase I/II, Non-Randomized, Single Site Study, Open-label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221942",
"publication_url": "https://clinicaltrials.gov/study/NCT07221942",
"title": "Pembrolizumab Maintenance After Enfortumab Vedotin/Pembrolizumab Induction in Front-Line Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fox Chase Cancer Center",
"sponsor_slug": "fox-chase-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369050",
"publication_url": "https://clinicaltrials.gov/study/NCT07369050",
"title": "Is the Provox ActiValve Only a Problem Solver? A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses After Total Laryngectomy With Tracheoesophageal Puncture",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2028-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06758401",
"publication_url": "https://clinicaltrials.gov/study/NCT06758401",
"title": "AN OPEN-LABEL, RANDOMIZED, CONTROLLED PHASE 3 STUDY OF SIGVOTATUG VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB COMPARED WITH PEMBROLIZUMAB MONOTHERAPY AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH PD-L1 HIGH (≥50% OF TUMOR CELLS EXPRESSING PD-L1), LOCALLY ADVANCED, UNRESECTABLE, OR METASTATIC NON-SMALL CELL LUNG CANCER (BE6A LUNG-02)",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2028-09-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05599360",
"publication_url": "https://clinicaltrials.gov/study/NCT05599360",
"title": "Vyxeos for Induction of Newly Diagnosed Low- or Intermediate-risk AML Patients, Age 18-70. A Pilot Study",
"has_exemption": false,
"start_date": "2022-08-07",
"completion_date": "2028-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Shaare Zedek Medical Center",
"sponsor_slug": "shaare-zedek-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06963827",
"publication_url": "https://clinicaltrials.gov/study/NCT06963827",
"title": "A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2028-09-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05611801",
"publication_url": "https://clinicaltrials.gov/study/NCT05611801",
"title": "AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY =2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS",
"has_exemption": false,
"start_date": "2022-12-09",
"completion_date": "2028-09-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959641",
"publication_url": "https://clinicaltrials.gov/study/NCT06959641",
"title": "A Phase 2 Open Label Study of XL092 as First Line Therapy in Radioiodine Refractory Differentiated Thyroid Cancer",
"has_exemption": false,
"start_date": "2025-06-06",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976216",
"publication_url": "https://clinicaltrials.gov/study/NCT06976216",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 1)",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976203",
"publication_url": "https://clinicaltrials.gov/study/NCT06976203",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06980480",
"publication_url": "https://clinicaltrials.gov/study/NCT06980480",
"title": "A Multicenter, Randomized, Controlled, Open-label, Group-Sequential, Phase 3 Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infection Prophylaxis Compared With Secondary Infection Prophylaxis in Adult Subjects With Multiple Myeloma Receiving B-Cell Maturation AntigenxCD3-Directed Bispecific Antibody Therapy",
"has_exemption": false,
"start_date": "2026-01-28",
"completion_date": "2028-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305754",
"publication_url": "https://clinicaltrials.gov/study/NCT06305754",
"title": "A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors",
"has_exemption": false,
"start_date": "2024-06-11",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07028853",
"publication_url": "https://clinicaltrials.gov/study/NCT07028853",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Mevrometostat (PF-06821497) With Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (MEVPRO-3)",
"has_exemption": false,
"start_date": "2025-09-28",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847542",
"publication_url": "https://clinicaltrials.gov/study/NCT06847542",
"title": "A Phase IIIb, Multicenter, Single-arm Study Assessing the Effectiveness, Safety and Patient Reported Outcomes of a 36-week Refill Exchange Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-11-27",
"completion_date": "2028-09-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05244486",
"publication_url": "https://clinicaltrials.gov/study/NCT05244486",
"title": "Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy",
"has_exemption": false,
"start_date": "2022-03-12",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Charitable Union for the Research and Education of Peyronie's Disease",
"sponsor_slug": "charitable-union-for-the-research-and-education-of-peyronies-disease",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06872892",
"publication_url": "https://clinicaltrials.gov/study/NCT06872892",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg Administered Once Daily for up to 76 Weeks in Patients With Bronchiectasis (The AIRTIVITY™ Study)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094516",
"publication_url": "https://clinicaltrials.gov/study/NCT07094516",
"title": "A Randomized, Placebo-controlled, Parallel Group, 72-week Study to Evaluate the Efficacy and Safety of VHB937 in Participants With Early Alzheimer's Disease Followed by an Extension",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-09-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06175000",
"publication_url": "https://clinicaltrials.gov/study/NCT06175000",
"title": "Maintenance Obinutuzumab for Primary Central Nervous System Lymphoma Complete or Partial Responders",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Providence Health & Services",
"sponsor_slug": "providence-health-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06158828",
"publication_url": "https://clinicaltrials.gov/study/NCT06158828",
"title": "A Phase I/II Pilot Study of Memory-like NK Cells to Consolidate TCRαβ T Cell Depleted Haploidentical Transplant in High-risk AML",
"has_exemption": false,
"start_date": "2024-05-15",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06514547",
"publication_url": "https://clinicaltrials.gov/study/NCT06514547",
"title": "Vaccine Immunity and Inflammation in the Aging Person Living With HIV",
"has_exemption": false,
"start_date": "2024-07-08",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Hennepin Healthcare Research Institute.",
"sponsor_slug": "hennepin-healthcare-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06570798",
"publication_url": "https://clinicaltrials.gov/study/NCT06570798",
"title": "A Phase 2a, Open Label, Multicenter, Platform Trial to Assess the Safety, Tolerability, and Efficacy of Inebilizumab and Blinatumomab in Subjects With Autoimmune Diseases",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07100080",
"publication_url": "https://clinicaltrials.gov/study/NCT07100080",
"title": "IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2028-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015996",
"publication_url": "https://clinicaltrials.gov/study/NCT07015996",
"title": "Efficacy of Tezepelumab in Peanut Oral Immunotherapy: a Double-Blind, Randomized, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-18",
"completion_date": "2028-09-16",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990529",
"publication_url": "https://clinicaltrials.gov/study/NCT06990529",
"title": "An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Leniolisib for Immune Dysregulation in Primary Immunodeficiency Disorders",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2028-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharming Technologies B.V.",
"sponsor_slug": "pharming-technologies-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228403",
"publication_url": "https://clinicaltrials.gov/study/NCT07228403",
"title": "A 104-week, Multicenter, Open-label, Single-arm, Phase 3 Extension Trial Investigating the Long-term Safety and Efficacy of Glepaglutide in Adult Patients With Short Bowel Syndrome (SBS) Rolling Over From the EASE SBS 2 or 3 Trials",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2028-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Zealand Pharma",
"sponsor_slug": "zealand-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04889430",
"publication_url": "https://clinicaltrials.gov/study/NCT04889430",
"title": "A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy",
"has_exemption": false,
"start_date": "2022-01-17",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05239741",
"publication_url": "https://clinicaltrials.gov/study/NCT05239741",
"title": "A Phase 3 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer (MK-3475-C66)",
"has_exemption": false,
"start_date": "2022-04-02",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07196722",
"publication_url": "https://clinicaltrials.gov/study/NCT07196722",
"title": "A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-09-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05587712",
"publication_url": "https://clinicaltrials.gov/study/NCT05587712",
"title": "A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children From 1 to Less Than 18 Years of Age With PAH on Standard of Care",
"has_exemption": false,
"start_date": "2023-01-19",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06057935",
"publication_url": "https://clinicaltrials.gov/study/NCT06057935",
"title": "ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma",
"has_exemption": false,
"start_date": "2023-09-21",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185009",
"publication_url": "https://clinicaltrials.gov/study/NCT07185009",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-01-07",
"completion_date": "2028-09-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288034",
"publication_url": "https://clinicaltrials.gov/study/NCT07288034",
"title": "Immunotherapy Biomarker Collection for Metastatic NSCLC to Inform Adaptive Personalized Models Targeting Resistance (IMMUNO-BIOMAP)",
"has_exemption": false,
"start_date": "2026-09-21",
"completion_date": "2028-09-22",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01499888",
"publication_url": "https://clinicaltrials.gov/study/NCT01499888",
"title": "Phase I/II Study of Allogeneic Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease (SCD)",
"has_exemption": false,
"start_date": "2011-11-11",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06882785",
"publication_url": "https://clinicaltrials.gov/study/NCT06882785",
"title": "A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06726148",
"publication_url": "https://clinicaltrials.gov/study/NCT06726148",
"title": "An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2-negative Breast Cancer and Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-04-03",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223528",
"publication_url": "https://clinicaltrials.gov/study/NCT07223528",
"title": "A Phase 2a Single Arm Open Label Safety and Efficacy Study of Telaglenastat Plus Standard of Care in Adults With Functional Class Ii-iii Precapillary Pulmonary Hypertension Across Wsph Groups 1-4",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-09-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Chan, Stephen, MD, PhD",
"sponsor_slug": "chan-stephen-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06435429",
"publication_url": "https://clinicaltrials.gov/study/NCT06435429",
"title": "A Phase 3, Randomized, Open-label, Multicenter, Controlled Study to Evaluate the Efficacy and Safety of Zanidatamab in Combination With Physician's Choice Chemotherapy Compared to Trastuzumab in Combination With Physician's Choice Chemotherapy for the Treatment of Participants With Metastatic HER2-positive Breast Cancer Who Have Progressed on, or Are Intolerant to, Previous Trastuzumab Deruxtecan Treatment",
"has_exemption": false,
"start_date": "2024-08-13",
"completion_date": "2028-09-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06321601",
"publication_url": "https://clinicaltrials.gov/study/NCT06321601",
"title": "A Phase 3, Open-label, Uncontrolled Single-arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Avacopan in Combination With a Rituximab or a Cyclophosphamide-containing Regimen in Children From 6 Years to < 18 Years of Age With Active ANCA-associated Vasculitis (AAV)",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2028-09-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06687603",
"publication_url": "https://clinicaltrials.gov/study/NCT06687603",
"title": "Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms",
"has_exemption": false,
"start_date": "2025-03-10",
"completion_date": "2028-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213609",
"publication_url": "https://clinicaltrials.gov/study/NCT07213609",
"title": "A Phase 1/2 Open-label, Multicenter Study of Oral GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Adult Participants With Mismatch Repair-deficient (dMMR) or Microsatellite Instability-High (MSI-H) Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2028-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06143891",
"publication_url": "https://clinicaltrials.gov/study/NCT06143891",
"title": "A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease (cGVHD)",
"has_exemption": false,
"start_date": "2024-01-23",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288073",
"publication_url": "https://clinicaltrials.gov/study/NCT07288073",
"title": "A Feasibility Study of Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma and Merkel Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-09-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Karam Khaddour",
"sponsor_slug": "karam-khaddour",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01697371",
"publication_url": "https://clinicaltrials.gov/study/NCT01697371",
"title": "Phase I-II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases",
"has_exemption": false,
"start_date": "2012-08-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Loma Linda University",
"sponsor_slug": "loma-linda-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01912651",
"publication_url": "https://clinicaltrials.gov/study/NCT01912651",
"title": "The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery",
"has_exemption": false,
"start_date": "2013-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02796937",
"publication_url": "https://clinicaltrials.gov/study/NCT02796937",
"title": "An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha1-Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Grifols Therapeutics LLC",
"sponsor_slug": "grifols-therapeutics-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03398135",
"publication_url": "https://clinicaltrials.gov/study/NCT03398135",
"title": "A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03900468",
"publication_url": "https://clinicaltrials.gov/study/NCT03900468",
"title": "Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)",
"has_exemption": false,
"start_date": "2020-03-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MedtronicNeuro",
"sponsor_slug": "medtronicneuro",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375033",
"publication_url": "https://clinicaltrials.gov/study/NCT04375033",
"title": "CSP #2014 - Comparative Effectiveness of Two Formulations of Buprenorphine for Treating Opioid Use Disorder in Veterans (VA-BRAVE)",
"has_exemption": false,
"start_date": "2020-11-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04545736",
"publication_url": "https://clinicaltrials.gov/study/NCT04545736",
"title": "Oral Metformin for Treatment of ABCA4 Retinopathy",
"has_exemption": false,
"start_date": "2020-11-23",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Eye Institute (NEI)",
"sponsor_slug": "national-eye-institute-nei",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04535271",
"publication_url": "https://clinicaltrials.gov/study/NCT04535271",
"title": "TAGGED: A Phase 2 Study Using Low Dose/Metronomic Trabectedin, Gemcitabine, and Dacarbazine as 2nd/3rd/4th Line Therapy for Advanced Soft Tissue Sarcoma",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04914507",
"publication_url": "https://clinicaltrials.gov/study/NCT04914507",
"title": "A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Spine Foundation",
"sponsor_slug": "pediatric-spine-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04526938",
"publication_url": "https://clinicaltrials.gov/study/NCT04526938",
"title": "Clinical Outcomes, Radiation Dosage, and Quality of Life in Patients Treated With Fenestrated Stent Grafts for Complex Thoracoabdominal and Abdominal Aortic Aneurysms, Thoracoabdominal Aortic Aneurysms Secondary to Aortic Dissections",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04372615",
"publication_url": "https://clinicaltrials.gov/study/NCT04372615",
"title": "A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease",
"has_exemption": false,
"start_date": "2022-03-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05197881",
"publication_url": "https://clinicaltrials.gov/study/NCT05197881",
"title": "Daily Adaptive External Beam Radiation Therapy in the Treatment of Carcinoma of the Cervix: A Prospective Trial of an Individualized Approach for Intestinal Toxicity Reduction (ARTIA-Cervix)",
"has_exemption": false,
"start_date": "2022-05-03",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Varian, a Siemens Healthineers Company",
"sponsor_slug": "varian-a-siemens-healthineers-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05613413",
"publication_url": "https://clinicaltrials.gov/study/NCT05613413",
"title": "LUNG-IST-127: A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab (CP) for Patients With Metastatic sqNSCLC With Disease Control Following Induction Therapy",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05765812",
"publication_url": "https://clinicaltrials.gov/study/NCT05765812",
"title": "A Phase 1/2 Open-label Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2023-05-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Debiopharm International SA",
"sponsor_slug": "debiopharm-international-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05941052",
"publication_url": "https://clinicaltrials.gov/study/NCT05941052",
"title": "Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB)- Technical Area (TA) 1: Diagnostics- Assessing Diagnostics At Point-of-care for Tuberculosis (ADAPT)",
"has_exemption": false,
"start_date": "2023-08-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05979441",
"publication_url": "https://clinicaltrials.gov/study/NCT05979441",
"title": "A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy",
"has_exemption": false,
"start_date": "2023-09-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05934487",
"publication_url": "https://clinicaltrials.gov/study/NCT05934487",
"title": "A Prospective, Multi-Center, Open Label, Randomized Control Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients",
"has_exemption": false,
"start_date": "2023-11-29",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Endotronix, Inc.",
"sponsor_slug": "endotronix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06056583",
"publication_url": "https://clinicaltrials.gov/study/NCT06056583",
"title": "Postpartum Activity and Expression of BCRP and OCT1 Drug Transporters in the Mammary Gland",
"has_exemption": false,
"start_date": "2023-12-04",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828069",
"publication_url": "https://clinicaltrials.gov/study/NCT05828069",
"title": "Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis",
"has_exemption": false,
"start_date": "2024-03-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128356",
"publication_url": "https://clinicaltrials.gov/study/NCT06128356",
"title": "Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06464692",
"publication_url": "https://clinicaltrials.gov/study/NCT06464692",
"title": "A Phase 1b Study to Evaluate Safety and Pharmacokinetics (PK) of Telisotuzumab Adizutecan (ABBV-400) in Chinese Subjects With Unresectable Locally Advanced/Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06083480",
"publication_url": "https://clinicaltrials.gov/study/NCT06083480",
"title": "Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463028",
"publication_url": "https://clinicaltrials.gov/study/NCT06463028",
"title": "An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel, and a Substudy Evaluating PIKTOR With Paclitaxel Plus an Insulin-Suppressing Diet, in Patients With Advanced or Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Faeth Therapeutics",
"sponsor_slug": "faeth-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699212",
"publication_url": "https://clinicaltrials.gov/study/NCT06699212",
"title": "A Phase 3 Multicenter, Randomized, Open-label Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab Versus Standard of Care in the First-line Treatment of Patients With Locoregional Recurrence of Squamous Cell Carcinoma of the Head and Neck (HNSCC) With No Distant Metastases",
"has_exemption": false,
"start_date": "2024-12-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rakuten Medical, Inc.",
"sponsor_slug": "rakuten-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05046106",
"publication_url": "https://clinicaltrials.gov/study/NCT05046106",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke",
"has_exemption": false,
"start_date": "2025-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moleac Pte Ltd.",
"sponsor_slug": "moleac-pte-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931561",
"publication_url": "https://clinicaltrials.gov/study/NCT06931561",
"title": "Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inova Health Care Services",
"sponsor_slug": "inova-health-care-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649058",
"publication_url": "https://clinicaltrials.gov/study/NCT06649058",
"title": "EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active Systemic Therapy Options",
"has_exemption": false,
"start_date": "2025-02-14",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847321",
"publication_url": "https://clinicaltrials.gov/study/NCT06847321",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lighthouse Pharmaceuticals, Inc.",
"sponsor_slug": "lighthouse-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06236607",
"publication_url": "https://clinicaltrials.gov/study/NCT06236607",
"title": "Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Medical Center",
"sponsor_slug": "boston-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06406777",
"publication_url": "https://clinicaltrials.gov/study/NCT06406777",
"title": "Validation of MRI, CT and Pulmonary Function Tests for Early Detection of Chronic Lung Allograft Dysfunction",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sean Fain",
"sponsor_slug": "sean-fain",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05940493",
"publication_url": "https://clinicaltrials.gov/study/NCT05940493",
"title": "A Phase 2 Multicenter, Double-blind, Randomized-controlled Study of Abemaciclib (CDK4 and 6 Inhibitor) in Newly Diagnosed RB-proficient Grade 3 Meningioma Participants",
"has_exemption": false,
"start_date": "2025-03-24",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nader Sanai",
"sponsor_slug": "nader-sanai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06880744",
"publication_url": "https://clinicaltrials.gov/study/NCT06880744",
"title": "Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who Are Naïve to Targeted Therapies",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649695",
"publication_url": "https://clinicaltrials.gov/study/NCT06649695",
"title": "A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047716",
"publication_url": "https://clinicaltrials.gov/study/NCT07047716",
"title": "A Phase 3, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Once-Yearly Intramuscular Lenacapavir for HIV Pre-exposure Prophylaxis (PrEP) in People With an Indication for PrEP",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112183",
"publication_url": "https://clinicaltrials.gov/study/NCT07112183",
"title": "An Open Label Study to Assess Efficacy of Oral Treprostinil Titrated to 3.0mg Three Times Daily or Highest Tolerable Dose in 30 Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Resistant to Standard Vasodilatory Therapy",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179601",
"publication_url": "https://clinicaltrials.gov/study/NCT07179601",
"title": "Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799494",
"publication_url": "https://clinicaltrials.gov/study/NCT06799494",
"title": "Comparing the Antibody and B Cell Responses Induced by 1- or 2-dose 9-valent HPV (9vHPV) Vaccination in Healthy Adults",
"has_exemption": false,
"start_date": "2025-08-06",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07128589",
"publication_url": "https://clinicaltrials.gov/study/NCT07128589",
"title": "Clinical Evaluation of 3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York University",
"sponsor_slug": "new-york-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833320",
"publication_url": "https://clinicaltrials.gov/study/NCT06833320",
"title": "A Double-blind, Prospective, Randomized Trial of Propranolol for the Treatment of Postoperative Chylothorax After Open Cardiac Surgery",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "June Wu",
"sponsor_slug": "june-wu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197827",
"publication_url": "https://clinicaltrials.gov/study/NCT07197827",
"title": "A Phase 1/2, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL242 Monotherapy and Combinations in Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MediLink Therapeutics (Suzhou) Co., Ltd.",
"sponsor_slug": "medilink-therapeutics-suzhou-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043608",
"publication_url": "https://clinicaltrials.gov/study/NCT07043608",
"title": "A Phase II Study of Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases in Patients Previously Treated With Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kelly Fitzgerald, MD",
"sponsor_slug": "kelly-fitzgerald-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07101809",
"publication_url": "https://clinicaltrials.gov/study/NCT07101809",
"title": "Evaluating the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation (SURE) With the CVAC® System Compared to Standard Ureteroscopy With no Suction for the Treatment of Renal Stones: a Prospective, Randomized Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Calyxo, Inc.",
"sponsor_slug": "calyxo-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201298",
"publication_url": "https://clinicaltrials.gov/study/NCT07201298",
"title": "A Prospective Contralateral Comparison of Ray-Tracing Guided LASIK (WaveLight® Plus LASIK) vs. Small Incision Lenticule Extraction (SMILE® Pro) Using VisuMax® 800, or Wavefront Optimized LASIK or Topography Guided LASIK (Contoura LASIK): A Three-Phase Visual Outcomes Study.",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoopes Vision",
"sponsor_slug": "hoopes-vision",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07183644",
"publication_url": "https://clinicaltrials.gov/study/NCT07183644",
"title": "Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745908",
"publication_url": "https://clinicaltrials.gov/study/NCT06745908",
"title": "ResQ201A: Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07070219",
"publication_url": "https://clinicaltrials.gov/study/NCT07070219",
"title": "A Single-Arm, Open-Label, Multi-Center, Phase 1b/ 2 Study to Evaluate the Safety, Efficacy, and Cellular Pharmacokinetic Profile of CTD402 in Participants With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) (TENACITY-01)",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BIOHENG THERAPEUTICS US LLC",
"sponsor_slug": "bioheng-therapeutics-us-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186660",
"publication_url": "https://clinicaltrials.gov/study/NCT07186660",
"title": "Evaluation of a Novel Insulin Sensitizer on Glycemic Control, Insulin Usage, and Cardiovascular Biomarkers in People With Type 1 Diabetes Who Use Closed-loop Automated Insulin Delivery",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06983470",
"publication_url": "https://clinicaltrials.gov/study/NCT06983470",
"title": "Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral Neuromodulation",
"has_exemption": false,
"start_date": "2025-10-16",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224542",
"publication_url": "https://clinicaltrials.gov/study/NCT07224542",
"title": "Smart Soft Contact Lenses for Continuous 24-hour Monitoring of Intraocular Pressure in Glaucoma Care",
"has_exemption": false,
"start_date": "2025-10-19",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215325",
"publication_url": "https://clinicaltrials.gov/study/NCT07215325",
"title": "The Effects of Doxycycline on Inflammation and the Microbiome: 'Flipping the Script' on STI PEP",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07256392",
"publication_url": "https://clinicaltrials.gov/study/NCT07256392",
"title": "A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Who Have Completed CDX0159-12 or CDX0159-13",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celldex Therapeutics",
"sponsor_slug": "celldex-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07182227",
"publication_url": "https://clinicaltrials.gov/study/NCT07182227",
"title": "A Phase 1/2 Multicenter, Open Label, Two-part Study (Single Ascending Dose [Part 1], and Dose Expansion [Part 2]) to Evaluate Safety, Tolerability and Efficacy of PS-002, a Gene Therapy for the Treatment of Adult Participants With Primary IgA Nephropathy",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Purespring Therapeutics Limited",
"sponsor_slug": "purespring-therapeutics-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179952",
"publication_url": "https://clinicaltrials.gov/study/NCT07179952",
"title": "A Study to Evaluate Efficacy and Safety of Slow Release DHEA",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049055",
"publication_url": "https://clinicaltrials.gov/study/NCT07049055",
"title": "A Phase I/IIa Randomized Clinical Trial to Evaluate the Efficacy of EGFR-targeted, PNU-159682-packaged Nanocells & Glycolipid-Packaged Nanocells in Combination With Gemcitabine & Nab-paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Engeneic Pty Limited",
"sponsor_slug": "engeneic-pty-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07132190",
"publication_url": "https://clinicaltrials.gov/study/NCT07132190",
"title": "A Double-Blind Phase II Randomized Study of Adaptively Delivered LINAC-Based Stereotactic Radiation for Volatile Brain Metastases With Same-Day Planning and Margin Reduction",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ayal A. Aizer, MD",
"sponsor_slug": "ayal-a-aizer-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278479",
"publication_url": "https://clinicaltrials.gov/study/NCT07278479",
"title": "A Phase 1/2a Study to Assess Safety, Tolerability, and Efficacy of [212Pb]Pb-DOTAM-MAM279 in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Molecular Partners AG",
"sponsor_slug": "molecular-partners-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282847",
"publication_url": "https://clinicaltrials.gov/study/NCT07282847",
"title": "A Single-Arm, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability and Efficacy of a Single Intravenous Infusion of AB-1009 in Adult Participants With Late Onset Pompe Disease (LOPD)",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AskBio Inc",
"sponsor_slug": "askbio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226791",
"publication_url": "https://clinicaltrials.gov/study/NCT07226791",
"title": "A Phase 2 Double-Blind, Placebo-Controlled, Adaptive, Dose-Escalation Study to Evaluate the Safety and Efficacy of AGN-151607-DP (USAN: gemibotulinumtoxinA) for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique, in Subjects Undergoing Open Abdominal Ventral Hernia Repair",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05249556",
"publication_url": "https://clinicaltrials.gov/study/NCT05249556",
"title": "Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone in the Treatment of Seizures Associated With Genetically Confirmed Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) in Pediatric Patients From 6 Months to Less Than 2 Years of Age.",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immedica Pharma AB",
"sponsor_slug": "immedica-pharma-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07006805",
"publication_url": "https://clinicaltrials.gov/study/NCT07006805",
"title": "RESET-MS: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979076",
"publication_url": "https://clinicaltrials.gov/study/NCT06979076",
"title": "A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MingSight Pharmaceuticals, Inc.",
"sponsor_slug": "mingsight-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05864313",
"publication_url": "https://clinicaltrials.gov/study/NCT05864313",
"title": "Gaze and Gait Training With Neuromodulation",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04301843",
"publication_url": "https://clinicaltrials.gov/study/NCT04301843",
"title": "Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2020-09-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04269902",
"publication_url": "https://clinicaltrials.gov/study/NCT04269902",
"title": "Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study",
"has_exemption": false,
"start_date": "2021-03-02",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05058651",
"publication_url": "https://clinicaltrials.gov/study/NCT05058651",
"title": "Randomized Phase II/III Trial of First Line Platinum/Etoposide With or Without Atezolizumab (NSC#783608) in Patients With Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)",
"has_exemption": false,
"start_date": "2022-06-28",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05518188",
"publication_url": "https://clinicaltrials.gov/study/NCT05518188",
"title": "A Phase 1/2 Open-label Intrathecal Administration of MELPIDA to Determine Its Safety and Efficacy for Patients with Spastic Paraplegia Type 50 (SPG50) Caused by Mutation in the AP4M1 Gene.",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Elpida Therapeutics SPC",
"sponsor_slug": "elpida-therapeutics-spc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05554328",
"publication_url": "https://clinicaltrials.gov/study/NCT05554328",
"title": "A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients With Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial",
"has_exemption": false,
"start_date": "2023-04-25",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06349434",
"publication_url": "https://clinicaltrials.gov/study/NCT06349434",
"title": "The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI",
"has_exemption": false,
"start_date": "2023-10-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06099444",
"publication_url": "https://clinicaltrials.gov/study/NCT06099444",
"title": "The Effects of Muscle Synergy-Based Biofeedback During Gait Rehabilitation for Individuals With Chronic Stroke",
"has_exemption": false,
"start_date": "2024-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shirley Ryan AbilityLab",
"sponsor_slug": "shirley-ryan-abilitylab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06516978",
"publication_url": "https://clinicaltrials.gov/study/NCT06516978",
"title": "A Prospective, Open-Label, Multicenter, Randomized Controlled Study Comparing the Efficacy and Safety of Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Combined With Orelabrutinib/Chidamide/Venetoclax/Lenalidomide/PD1 (Pola-RCHP-X) Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With Diffuse Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital with Nanjing Medical University",
"sponsor_slug": "the-first-affiliated-hospital-with-nanjing-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06635629",
"publication_url": "https://clinicaltrials.gov/study/NCT06635629",
"title": "Phase II Prospective Evaluation of Desmopressin Stimulation Test Performance in ACTH-dependent Cushing s Syndrome",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06644183",
"publication_url": "https://clinicaltrials.gov/study/NCT06644183",
"title": "A Phase 1/2, Open Label, Study of Roginolisib (IOA-244), an Orally Bioavailable, Selective PI3Kδ Inhibitor in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) in Combination With Venetoclax and Rituximab",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jennifer R. Brown, MD, PhD",
"sponsor_slug": "jennifer-r-brown-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06480760",
"publication_url": "https://clinicaltrials.gov/study/NCT06480760",
"title": "Effects of Carnosine In Patients With Peripheral Arterial Disease Patients; Randomized Intervention Trial (CIPHER)",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shahid Baba",
"sponsor_slug": "shahid-baba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209449",
"publication_url": "https://clinicaltrials.gov/study/NCT07209449",
"title": "Phase II Study of ELacestrant in Combination With Abemaciclib or Elacestrant Alone In p53 Wild Type, Estrogen Receptor-positive Advanced or recurrenT Endometrial Cancer (ELITE)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986174",
"publication_url": "https://clinicaltrials.gov/study/NCT06986174",
"title": "A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2025-11-21",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Shayna Sarosiek, MD",
"sponsor_slug": "shayna-sarosiek-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217938",
"publication_url": "https://clinicaltrials.gov/study/NCT07217938",
"title": "TRADstat: Novel Treatment of Radiation Associated Dysphagia With Statins",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Peter MacCallum Cancer Centre, Australia",
"sponsor_slug": "peter-maccallum-cancer-centre-australia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07013591",
"publication_url": "https://clinicaltrials.gov/study/NCT07013591",
"title": "Randomized Clinical Trial of β Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06408246",
"publication_url": "https://clinicaltrials.gov/study/NCT06408246",
"title": "ACE-D: Accelerating Cognition-guided Signatures to Enhance Translation in Depression: Clinical Trial",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06833008",
"publication_url": "https://clinicaltrials.gov/study/NCT06833008",
"title": "An Open-label, Phase I/II First-in-human, Dose Escalation and Confirmation Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Anti-tumour Activity of IPN01195 as Single Agent in Adult Participants With Advanced Solid Tumours",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2028-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06202274",
"publication_url": "https://clinicaltrials.gov/study/NCT06202274",
"title": "Clinical Study to Evaluate the Safety and Efficacy of Candela Technology",
"has_exemption": false,
"start_date": "2023-10-04",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06003387",
"publication_url": "https://clinicaltrials.gov/study/NCT06003387",
"title": "Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B With Detectable Pretreatment AAV5 Neutralizing Antibodies",
"has_exemption": false,
"start_date": "2024-01-30",
"completion_date": "2028-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05835310",
"publication_url": "https://clinicaltrials.gov/study/NCT05835310",
"title": "A Phase III, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Moderate to Severe Active Systemic Lupus Erythematosus While on Background Standard of Care Therapy",
"has_exemption": false,
"start_date": "2024-03-14",
"completion_date": "2028-10-05",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00801489",
"publication_url": "https://clinicaltrials.gov/study/NCT00801489",
"title": "A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia",
"has_exemption": false,
"start_date": "2007-04-04",
"completion_date": "2028-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01878617",
"publication_url": "https://clinicaltrials.gov/study/NCT01878617",
"title": "A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma",
"has_exemption": false,
"start_date": "2013-06-23",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06492291",
"publication_url": "https://clinicaltrials.gov/study/NCT06492291",
"title": "A Phase 3, Open-label Extension Study to Evaluate the Safety and Efficacy of MK-0616 in Adults With Hypercholesterolemia",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223047",
"publication_url": "https://clinicaltrials.gov/study/NCT07223047",
"title": "A Phase 1/2a, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of BMS-986523 As Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072781",
"publication_url": "https://clinicaltrials.gov/study/NCT06072781",
"title": "A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib Versus Investigator's Choice of Treatment in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC) (RAMP 301)",
"has_exemption": false,
"start_date": "2024-03-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Verastem, Inc.",
"sponsor_slug": "verastem-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06815003",
"publication_url": "https://clinicaltrials.gov/study/NCT06815003",
"title": "Phase-2 Study of Vedolizumab Plus Post-Transplant Cyclophosphamide and Short Course Tacrolimus for Graft-versus-Host Disease Prevention After Reduced Intensity Conditioning Peripheral Blood Stem Cell Allogeneic Hematopoietic Cell Transplantation",
"has_exemption": false,
"start_date": "2025-04-18",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06796998",
"publication_url": "https://clinicaltrials.gov/study/NCT06796998",
"title": "Phase 2 Trial of Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2028-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Izidore Lossos, MD",
"sponsor_slug": "izidore-lossos-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04067336",
"publication_url": "https://clinicaltrials.gov/study/NCT04067336",
"title": "A Phase 1/2 First in Human Study of the Menin-MLL(KMT2A) Inhibitor KO-539 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2019-09-12",
"completion_date": "2028-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Kura Oncology, Inc.",
"sponsor_slug": "kura-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572384",
"publication_url": "https://clinicaltrials.gov/study/NCT06572384",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Belimumab Administered Subcutaneously in Adults With Interstitial Lung Disease (ILD) Associated With Connective Tissue Disease (CTD)",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2028-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197944",
"publication_url": "https://clinicaltrials.gov/study/NCT07197944",
"title": "A Phase 3, Double-blind, Randomized, Parallel Group, Placebo-controlled, Multicenter Trial to Confirm the Efficacy and Safety of Glepaglutide 10 mg Twice Weekly, Followed by a Long-term, Open-label Safety Evaluation in Patients With Short Bowel Syndrome-intestinal Failure (SBS-IF)",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2028-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Zealand Pharma",
"sponsor_slug": "zealand-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06818643",
"publication_url": "https://clinicaltrials.gov/study/NCT06818643",
"title": "A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-25",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109414",
"publication_url": "https://clinicaltrials.gov/study/NCT07109414",
"title": "Randomized Phase 2/3 Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2028-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novita Pharmaceuticals, Inc.",
"sponsor_slug": "novita-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02407028",
"publication_url": "https://clinicaltrials.gov/study/NCT02407028",
"title": "Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial",
"has_exemption": false,
"start_date": "2018-06-25",
"completion_date": "2028-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Gaylan Rockswold",
"sponsor_slug": "gaylan-rockswold",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05755386",
"publication_url": "https://clinicaltrials.gov/study/NCT05755386",
"title": "A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)",
"has_exemption": false,
"start_date": "2023-10-02",
"completion_date": "2028-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05451849",
"publication_url": "https://clinicaltrials.gov/study/NCT05451849",
"title": "A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "TCR2 Therapeutics",
"sponsor_slug": "tcr2-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06430801",
"publication_url": "https://clinicaltrials.gov/study/NCT06430801",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06678659",
"publication_url": "https://clinicaltrials.gov/study/NCT06678659",
"title": "A Phase 1 / 2, Open-Label Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Recursion Pharmaceuticals Inc.",
"sponsor_slug": "recursion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952453",
"publication_url": "https://clinicaltrials.gov/study/NCT05952453",
"title": "A Phase II Study in Newly Diagnosed Stage III/IV Epithelial Ovarian Cancer Evaluating Carbo/Taxol/Pembro in Patients Receiving Neoadjuvant Chemotherapy (NACT) Followed by Olaparib/Pembro Maintenance",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06873789",
"publication_url": "https://clinicaltrials.gov/study/NCT06873789",
"title": "A Phase 1/2, Open-Label, Multicenter Study of INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976619",
"publication_url": "https://clinicaltrials.gov/study/NCT06976619",
"title": "The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People",
"has_exemption": false,
"start_date": "2025-10-03",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213817",
"publication_url": "https://clinicaltrials.gov/study/NCT07213817",
"title": "An Open-Label, Phase I/II First-in-Human, Dose Escalation, Dose Optimisation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 as Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumours.",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308834",
"publication_url": "https://clinicaltrials.gov/study/NCT07308834",
"title": "Phase 1/2a Study to Evaluate the Safety and Tolerability Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CarthroniX, Inc.",
"sponsor_slug": "carthronix-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03219359",
"publication_url": "https://clinicaltrials.gov/study/NCT03219359",
"title": "Maintenance in Autologous Stem Cell Transplant for Crohn's Disease (MASCT - CD)",
"has_exemption": false,
"start_date": "2018-02-22",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aaron Etra",
"sponsor_slug": "aaron-etra",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03503331",
"publication_url": "https://clinicaltrials.gov/study/NCT03503331",
"title": "UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy",
"has_exemption": false,
"start_date": "2018-04-20",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03614949",
"publication_url": "https://clinicaltrials.gov/study/NCT03614949",
"title": "Phase II Study of Stereotactic Body Radiation Therapy and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer",
"has_exemption": false,
"start_date": "2019-01-29",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03833154",
"publication_url": "https://clinicaltrials.gov/study/NCT03833154",
"title": "A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab With Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Unresected Stage I/II, Lymph-node Negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515) Osimertinib Following SBRT, a Single Arm Cohort for Patients With Unresected Stage I/II, Lymph Node Negative NSCLC Harboring a Sensitizing EGFR Mutation",
"has_exemption": false,
"start_date": "2019-03-06",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03821129",
"publication_url": "https://clinicaltrials.gov/study/NCT03821129",
"title": "GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study",
"has_exemption": false,
"start_date": "2019-07-25",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04230109",
"publication_url": "https://clinicaltrials.gov/study/NCT04230109",
"title": "A Phase 2 Study of Response-guided Neoadjuvant Sacituzumab Govitecan (IMMU-132) in Patients With Localized Triple-Negative Breast Cancer (NeoSTAR)",
"has_exemption": false,
"start_date": "2020-07-14",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04613596",
"publication_url": "https://clinicaltrials.gov/study/NCT04613596",
"title": "A Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation",
"has_exemption": false,
"start_date": "2020-12-02",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mirati Therapeutics Inc.",
"sponsor_slug": "mirati-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04411823",
"publication_url": "https://clinicaltrials.gov/study/NCT04411823",
"title": "Prediction of Post-laparoscopic Sleeve Gastrectomy Gastroesophageal Reflux Disease With an Endolumenal Functional Lumen Imaging Probe (EndoFLIP)",
"has_exemption": false,
"start_date": "2021-02-01",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05153772",
"publication_url": "https://clinicaltrials.gov/study/NCT05153772",
"title": "A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in Subjects With Somatostatin Receptor Expressing Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2021-12-21",
"completion_date": "2028-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Orano Med LLC",
"sponsor_slug": "orano-med-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}